Medizone Home

Russia registers new Covid-19 drug to keep complications caused by virus ‘under control’

Russian developers have registered a new drug that may help alleviate the harshest complications caused by Covid-19, including lung failure. It’s hoped the treatment can buy time before a vaccine is found.

Levilimab is the second medication to receive state approval through a fast-track mechanism, implemented to give doctors more options to tackle the virus, which has already infected more than 459,000 and killed 5,725 in Russia, according to official statistics.

By reducing the Covid-19 mortality rate, Levilimab will allow Russia to “buy time” before the vaccine against the coronavirus is made, and “the vaccine is surely coming soon,” .

The drug is aimed at curbing the so-called ‘cytokine storm,’ a common complication from Covid-19 when the sick person’s immune system overreacts to the virus and the excessive inflammation leads to fatal outcome.

Levilimab’s highlight is that it can be administered not only to patients already in a serious condition, but used as a prophylactic to “prevent the ‘cytokine storm’ from occurring and allowing the patient to avoid intensive care and lung ventilation,” he pointed out.

The drug, which will go into the market under the brand ILSIRA, is administered hypodermically unlike its foreign counterparts, which get into the system through the intravenous route.

Levilimab has proven itself as effective as its foreign counterparts and increased the speed of recovery for patients, Ekaterina Trifonova, who heads the infectious ward at the Central Clinical Hospital in Moscow, where the drug underwent clinical testing, told RT. During the first two weeks of trials, out of 45 Covid-19 patients who got the drug, ten were discharged, including a 92-year-old-man, while the rest remained in satisfactory condition, she added.

Source: Biocad press release

Pharmagora Plus – Paris – cancelled June 27-28, 2020 – new dates March 13-14, 2021

Due to the current situation of the coronavirus epidemy, the French Minister of Health, Mr Olivier Véran, has forbidden the organization of any event with more than 5000 delegates in a closed environment. As a result, PharmogaraPlus 2020 will not take place on the 27th and 28th of June 2020 at Paris Porte de Versailles, Hall 3.

PharmagoraPlus is now postponed to the 13th and 14th of March 2021.

We look forward to meeting you soon.


Thanks for visiting us at ARAB HEALTH 2020 – 27 to 30 January

Thank you for visiting us at Arab Health this year!

It was a great pleasure to have the opportunity again to speak in person with many of our business partners.

Maktoum Hall – Booth Number M.D33

27th to 30th January 2020.

For more information visit ARAB HEALTH exhibitor directory.


We support „Wings for Life“ and „Mc Donalds Kinderhilfe“

Das Medizone-Team wünscht einen guten Start in das Jahr 2020.

Wir unterstützen auch in diesem Jahr „Wings for Life“ und die „Mc Donalds Kinderhilfe“


Thanks for visting us at CPHI in Frankfurt

Thank you for visiting us at CHPI in Frankfurt this year!

It was a great pleasure to have the opportunity again to speak in person with many of our business partners.

„Wings for Life“ honors Medizone for continues support!

Wings for Life – Spinal Cord Research Foundation

Worldwide, millions of people are dependent on a wheelchair after having sustained a spinal cord injury, most often as the result of a traffic accident or a fall. Wings for Life is a not-for-profit spinal cord research foundation with the single mission to find the cure for spinal cord injury. Since 2004, Wings for Life has funded life-changing research projects and clinical trials around the globe. While the cure is still to be found, steady progress has been made. One hundred percent of donations will help work toward Wings for Life’s ultimate goal.

„It can happen to anyone of us. The question is not whether effective treatments and cures will be found, but when they will be found! We are proud to support Wings for Life!“

Gerhard Hoerl / MD Medizone Germany GmbH

Spinal cord injury must become curable!


Thanks for visiting us at Expopharm 2019

Thank you for visiting us at Expopharm in Düsseldorf this year!

It was a great pleasure to have the opportunity again to speak in person with many of our business partners.

Meet us at Expopharm 2019 – Düsseldorf 25th to 28th September

We will have a booth again this year at expopharm Düsseldorf and hope that we can welcome you again in Hall 3 / Booth D32

For more information visit expopharm exhibitor director

Meet us at Clinical Operations in Oncology Trial Europe 2018

Meet us at our Booth at Clinical Operations in Oncology Trial Europe 2018
at the Hilton Munich Airport from 14 – 15 November 2018.

We look forward to meeting you there!


Thanks for visiting us at Expopharm 2018!

Thank you for visiting us at Expopharm in Munich this year. It was a great pleasure to have the opportunity again to speak in person with many of our business partners.

One big subject was the safety of drugs which is always our number one priority. Therefore, long-term trusting business partnerships are of great importance to us.